A phase I trial with a hybrid cell vaccine in patients with metastatic melanoma

Advances in Experimental Medicine and Biology

Volumn 451, Issue , 1998, Pages 519-525

  Trefzer, U ^a   Weingart, G ^a   Chen, Y ^a   Adrian, K ^a   Audring, H ^a   Winter, H ^a   Guo, Y J ^b   Sterry, W ^a   Walden, P ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b SIDNEY KIMMEL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL INTERACTION; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; HUMAN CELL; HYBRID CELL; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; PRIORITY JOURNAL; SKIN METASTASIS; VACCINATION;

EID: 0031724155     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5357-1_80     Document Type: Article

References (9)

1. Juretic, A., Malenica, B., Juretic, E., Klein, J., and Nagy, Z.A. Helper effects required during in vivo priming for a cytolytic response to the H-Y antigen in nonresponder mice. J. Immunol., 134: 1408-1410, 1985.
2. Mitchison, N. A.. An exact comparison between the efficiency of two-and three-cell-type clusters mediating helper activity. Eur. J. Immunol. 20: 699-702, 1990.
3. Mitchison, N. A., and O'Malley, C., Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in-vivo cytolytic response. Eur. J. Immunol. 17: 1479-1483, 1987.
4. Stuhler, G., and Walden, P. Collaboration of helper and cytotoxic T lymphocytes. Eur. J. Immunol. 23: 2279-2286, 1993.
5. Borges, E., Wiesmüller, K.-H., Jung, G., and Walden, P. Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocyte responses. J. Immunol. Meth. 173: 253-263, 1994.
6. Grabbe, S., Beissert, S., Schwarz, T., and Granstein, R. Dendritic cells as initiators of tumour immune responses: a possible strategy for tumour immunotherapy? Immunology Today, 16: 117-121, 1995.
7. Chesnut, RW., and Grey, HM. Studies on the capacity of B-cells to serve as antigen-presenting cells. J. Immunol. 126: 1075-1079, 1981.
8. Stuhler, G., and Walden, P. Recruitment of helper T-cells for induction of tumour rejection by cytolytic T lymphocytes. Cancer Immunol. Immunother. 39: 342-345, 1994.
9. Guo, Y., Wu, M., Chen, H., Wang, X., Liu, G., Li, G., Ma, J., and Sy M. Effective tumour vaccine generated by fusion of hepatoma cells with activated B cells. Science. 263: 518-520, 1994.